These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG Front Immunol; 2019; 10():1946. PubMed ID: 31475007 [TBL] [Abstract][Full Text] [Related]
10. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Bested AC; Marshall LM Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325 [TBL] [Abstract][Full Text] [Related]
11. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S Front Immunol; 2019; 10():2545. PubMed ID: 31736966 [TBL] [Abstract][Full Text] [Related]
12. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors. Wirth K; Scheibenbogen C Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028 [TBL] [Abstract][Full Text] [Related]
13. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study. Mensah F; Bansal A; Berkovitz S; Sharma A; Reddy V; Leandro MJ; Cambridge G Clin Exp Immunol; 2016 May; 184(2):237-47. PubMed ID: 26646713 [TBL] [Abstract][Full Text] [Related]
14. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity. Proal A; Marshall T Front Pediatr; 2018; 6():373. PubMed ID: 30564562 [TBL] [Abstract][Full Text] [Related]
15. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms. Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625 [TBL] [Abstract][Full Text] [Related]
16. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin. Maes M; Twisk FN; Kubera M; Ringel K J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140 [TBL] [Abstract][Full Text] [Related]
17. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome. Maes M; Leunis JC; Geffard M; Berk M Neuro Endocrinol Lett; 2014; 35(6):445-53. PubMed ID: 25433843 [TBL] [Abstract][Full Text] [Related]
18. Allostatic overload in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Arroll MA Med Hypotheses; 2013 Sep; 81(3):506-8. PubMed ID: 23850395 [TBL] [Abstract][Full Text] [Related]
19. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Twisk FN; Maes M Neuro Endocrinol Lett; 2009; 30(3):284-99. PubMed ID: 19855350 [TBL] [Abstract][Full Text] [Related]
20. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome. Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]